These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20215405)

  • 1. Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.
    Liu Q; Jones TI; Tang VW; Brieher WM; Jones PL
    J Cell Sci; 2010 Apr; 123(Pt 7):1116-23. PubMed ID: 20215405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.
    Hanel ML; Sun CY; Jones TI; Long SW; Zanotti S; Milner D; Jones PL
    Differentiation; 2011 Feb; 81(2):107-18. PubMed ID: 20970242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.
    Sun CY; van Koningsbruggen S; Long SW; Straasheijm K; Klooster R; Jones TI; Bellini M; Levesque L; Brieher WM; van der Maarel SM; Jones PL
    J Mol Biol; 2011 Aug; 411(2):397-416. PubMed ID: 21699900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).
    Pistoni M; Shiue L; Cline MS; Bortolanza S; Neguembor MV; Xynos A; Ares M; Gabellini D
    PLoS Genet; 2013; 9(1):e1003186. PubMed ID: 23300487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
    Feeney SJ; McGrath MJ; Sriratana A; Gehrig SM; Lynch GS; D'Arcy CE; Price JT; McLean CA; Tupler R; Mitchell CA
    PLoS One; 2015; 10(2):e0117665. PubMed ID: 25695429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD).
    Jones TI; Parilla M; Jones PL
    PLoS One; 2016; 11(3):e0150938. PubMed ID: 26942723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscular dystrophy candidate gene FRG1 is critical for muscle development.
    Hanel ML; Wuebbles RD; Jones PL
    Dev Dyn; 2009 Jun; 238(6):1502-12. PubMed ID: 19097195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the effects of FSHD candidate gene expression in vertebrate muscle development.
    Wuebbles RD; Long SW; Hanel ML; Jones PL
    Int J Clin Exp Pathol; 2010 Mar; 3(4):386-400. PubMed ID: 20490329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status and future prospect of FSHD region gene 1.
    Hansda AK; Tiwari A; Dixit M
    J Biosci; 2017 Jun; 42(2):345-353. PubMed ID: 28569257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1.
    Gabellini D; D'Antona G; Moggio M; Prelle A; Zecca C; Adami R; Angeletti B; Ciscato P; Pellegrino MA; Bottinelli R; Green MR; Tupler R
    Nature; 2006 Feb; 439(7079):973-7. PubMed ID: 16341202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.
    Wuebbles RD; Hanel ML; Jones PL
    Dis Model Mech; 2009; 2(5-6):267-74. PubMed ID: 19383939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.
    D'Antona G; Brocca L; Pansarasa O; Rinaldi C; Tupler R; Bottinelli R
    J Physiol; 2007 Nov; 584(Pt 3):997-1009. PubMed ID: 17855756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSHD muscular dystrophy region gene 1 binds Suv4-20h1 histone methyltransferase and impairs myogenesis.
    Neguembor MV; Xynos A; Onorati MC; Caccia R; Bortolanza S; Godio C; Pistoni M; Corona DF; Schotta G; Gabellini D
    J Mol Cell Biol; 2013 Oct; 5(5):294-307. PubMed ID: 23720823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.
    Bortolanza S; Nonis A; Sanvito F; Maciotta S; Sitia G; Wei J; Torrente Y; Di Serio C; Chamberlain JR; Gabellini D
    Mol Ther; 2011 Nov; 19(11):2055-64. PubMed ID: 21829175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of facioscapulohumeral muscular dystrophy region gene 1 causes primary defects in myogenic stem cells.
    Xynos A; Neguembor MV; Caccia R; Licastro D; Nonis A; Di Serio C; Stupka E; Gabellini D
    J Cell Sci; 2013 May; 126(Pt 10):2236-45. PubMed ID: 23525014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DYC-1, a protein functionally linked to dystrophin in Caenorhabditis elegans is associated with the dense body, where it interacts with the muscle LIM domain protein ZYX-1.
    Lecroisey C; Martin E; Mariol MC; Granger L; Schwab Y; Labouesse M; Ségalat L; Gieseler K
    Mol Biol Cell; 2008 Mar; 19(3):785-96. PubMed ID: 18094057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
    Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
    Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
    Su Q; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
    Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
    Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.